Tracking T-cells in vivo with a new nano-sized MRI contrast agent
about
Imaging-based diagnosis of acute renal allograft rejection.Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune CellsDecreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid.A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRICharacterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune responseAdvances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future PerspectivesUnderstanding the particokinetics of engineered nanomaterials for safe and effective therapeutic applications.Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells.Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap.Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs).Genetically encoded iron-associated proteins as MRI reporters for molecular and cellular imaging.Effect of Gold Nanoparticle Size and Coating on Labeling Monocytes for CT Tracking.Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI.Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models.In vivo monitoring of rat macrophages labeled with poly(l-lysine)-iron oxide nanoparticles.
P2860
Q26751438-EA0D1324-8E57-4421-B168-205A2DC6FE92Q28076866-57F7C813-BFF0-456E-8063-88785A9C6053Q36807762-7C4436C5-2313-4978-BB0F-9BA2B4E1AA99Q36911124-A0A5F566-3BE2-455E-BDDC-027F9B6A4D93Q37280222-F859EC98-54FE-438B-8818-035D20D2497AQ37631684-04085387-F7B5-4D5D-AC99-42488758EDEDQ38066154-A1C415B2-4DC0-4C17-9871-69565880044AQ38097918-5888C55F-C3EC-4FCF-A22E-E59C933E695EQ38123394-744A0B82-9E77-4654-A36F-C898F538C787Q38243329-2FF00331-6C3A-4D47-8694-AA085C11B6F5Q38657755-BE9DDE12-635E-4EC0-A9FF-F3A3346E1DF4Q38720925-A04CB4A2-1A25-4552-8972-594E9C19AA2BQ39253138-E2A2D866-E60E-49D1-8793-5F66E9ECFABEQ47721500-3E250121-8C2A-4CE2-8C32-9E714C4BE74BQ50607711-A64D4399-4149-40A1-9375-58AFE35AFA27
P2860
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
@ast
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
@en
type
label
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
@ast
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
@en
prefLabel
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
@ast
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
@en
P2093
P2860
P1476
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
@en
P2093
Chih-Lung Chen
Haosen Zhang
Hsin-Hsin Shen
Shian-Jy Wang
T Kevin Hitchens
Wen-Yuan Hsieh
P2860
P304
P356
10.1016/J.NANO.2012.02.017
P577
2012-03-07T00:00:00Z